Healthcare is tough. There are few markets with more inertia and misaligned incentives than this.

With respect to pitching the product directly to clinicians, OP may have misunderstood his target market or overestimated the value proposition.

It seems like a very big request to ask a doctor to deviate from a treatment with which they already have a high level of experience.